Roche scraps sec­ond mid-stage schiz­o­phre­nia tri­al in as many years

Roche has ter­mi­nat­ed the sec­ond of two Phase II stud­ies test­ing its in­ves­ti­ga­tion­al schiz­o­phre­nia drug ralmi­taront, per an up­date to the fed­er­al clin­i­cal tri­als data­base …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER